Aflac, MetLife, and Unum Group are three of the most widely followed insurance carriers in U.S. markets, yet each occupies a distinct niche within the sector. Comparing them side by side offers a useful lens on how different business models respond to the same macro forces—interest rates, currency moves, credit conditions, and claims trends. This stock comparison is especially relevant for investors seeking income and capital discipline, as well as traders evaluating relative performance and market positioning across the insurance space. The sections below review each company's recent results, market behavior, and risk profile before presenting a head-to-head assessment and an AI-informed view of which name currently looks best positioned.
AFL, or Aflac Incorporated, is a supplemental health and life insurer best known for its dominant position in Japan and its iconic U.S. brand. Its latest quarterly results marked a sharp turnaround: the company swung to net earnings after a year-earlier loss, while adjusted earnings per share (EPS) rose by a double-digit percentage year over year. Higher net investment income and improved U.S. segment profitability—supported by group life and disability sales—drove the improvement, and new annualized premium sales in Japan climbed on strong demand for its Miraito cancer product. In recent weeks, the shares have traded in a narrow band, with analysts split between Hold and Underperform ratings. The core narrative remains a balance between resilient capital returns—including ongoing buybacks and a recent dividend increase—and structural pressure from declining Japan premiums and foreign-exchange sensitivity.
MET, or MetLife, Inc., is a globally diversified insurer offering life insurance, annuities, employee benefits, and asset management. Its latest quarter featured adjusted EPS up more than 20% year over year, beating consensus estimates, on the back of a 77% jump in Asia adjusted earnings and double-digit gains in Group Benefits and EMEA (Europe, the Middle East, and Africa). Reported net income fell, however, as stronger equity markets and rising long-term rates produced non-cash derivative losses. Private equity returns bolstered investment income, and the company continued its disciplined capital return, repurchasing shares and paying dividends while pursuing the PineBridge acquisition and a legacy variable annuity sale. Recent market activity has kept MET's shares well below the average analyst target, supporting a broadly Outperform consensus view, though expense and tax variability remain modest headwinds.
UNM, or Unum Group, is a leading provider of workplace benefits—primarily group disability, group life, and supplemental products through its Colonial Life brand. Its latest quarter showed solid top-line momentum, with premium income rising and strong sales growth in group disability, but reported net income dropped sharply as the company took a substantial reserve increase tied to long-term care (LTC) assumptions in its Closed Block. Adjusted operating EPS modestly missed estimates. On the positive side, Unum ceded a portion of its LTC reserves through a reinsurance transaction with Fortitude Re and returned roughly $1 billion to shareholders in the first nine months of the year, underscoring strong cash generation. Recent trading has been choppy, with the stock underperforming the broader market as investors weigh the drag of legacy LTC exposure against a still-robust core franchise.
For traders who prefer a systematic approach, Tickeron's Trending AI Robots page curates a focused selection from hundreds of AI trading bots that trade thousands of different tickers. Only the strategies best suited to current market conditions earn a place in this section, and each bot operates with its own trading style, timeframe, performance history, statistics, and ticker universe. Whether a bot is configured for swing trading, trend following, or momentum, the goal is to surface the models showing the strongest recent alignment with prevailing conditions. Exploring the Trending AI Robots list can help you identify which automated strategies are currently gaining traction across names like the three insurers compared here.
The clearest contrast among these three names is business mix. AFL is concentrated in supplemental health insurance and leans heavily on Japan, giving it elevated foreign-exchange and demographic sensitivity but a durable, high-margin franchise. MET offers the most geographic and product diversification, which smooths volatility but also dilutes any single growth driver. UNM is the most U.S.-centric and benefits-focused, with strong pricing power offset by legacy LTC risk.
On momentum, MET's broad segment gains and Asia strength stand out, while AFL's earnings rebound is arguably more concentrated in investment income and one product line. UNM's core growth is healthy, but reserve volatility has dominated recent sentiment. Valuation also differs: MET and AFL carry premium reputations for capital return and financial strength, while UNM screens cheaper on earnings but carries higher perceived tail risk. For risk-conscious investors, MET's diversification and scale may look most defensive; for those seeking leverage to a workplace-benefits cycle, UNM offers higher upside and higher uncertainty.
Based on trend consistency, earnings breadth, and relative stability, Tickeron's AI would likely favor MET among the three. Its latest results showed the most balanced, multi-segment earnings growth, supported by durable capital returns and an Outperform-leaning analyst consensus. AFL's strong rebound is notable but remains concentrated around Japan margins and investment income, while UNM's LTC reserve overhang introduces near-term uncertainty that trend-following models tend to penalize. That said, the ranking is probabilistic rather than definitive—catalyst timing, rate moves, and currency shifts could reorder these names quickly, so ongoing monitoring of trend signals remains essential.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Moving Average Convergence Divergence (MACD) for AFL turned positive on October 07, 2026. Looking at past instances where AFL's MACD turned positive, the stock continued to rise in 30 of 47 cases over the following month. The odds of a continued upward trend are 64%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on AFL as a result. In 47 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.
AFL moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for AFL crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 44%.
Following a +2.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where AFL advanced for three days, in 199 of 368 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.
The 10-day RSI Indicator for AFL moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 18 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 45%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AFL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 38%.
AFL broke above its upper Bollinger Band on October 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AFL entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. AFL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.993) is normal, around the industry mean (1.310). P/E Ratio (12.944) is within average values for comparable stocks, (19.517). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (0.463). Dividend Yield (0.020) settles around the average of (0.047) among similar stocks. AFL's P/S Ratio (3.313) is slightly higher than the industry average of (1.303).
The Tickeron PE Growth Rating for this company is 87 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MET advanced for three days, in 224 of 344 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on MET as a result. In 45 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 54%.
The Moving Average Convergence Divergence (MACD) for MET just turned positive on October 08, 2026. Looking at past instances where MET's MACD turned positive, the stock continued to rise in 25 of 51 cases over the following month. The odds of a continued upward trend are 49%.
MET moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MET crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 53%.
The 10-day RSI Indicator for MET moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 26 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 55%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.
MET broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MET entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 23 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 26 (best 1 - 100 worst), indicating outstanding price growth. MET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 54 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MET's P/B Ratio (2.288) is slightly higher than the industry average of (1.310). P/E Ratio (18.787) is within average values for comparable stocks, (19.517). Projected Growth (PEG Ratio) (0.506) is also within normal values, averaging (0.463). Dividend Yield (0.024) settles around the average of (0.047) among similar stocks. P/S Ratio (0.824) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Aroon Indicator for UNM entered a downward trend on October 12, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 64 similar instances where the Aroon Indicator formed such a pattern. In 35 of the 64 cases the stock moved lower. This puts the odds of a downward move at 55%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 37 of 74 cases where UNM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 50%.
The Momentum Indicator moved below the 0 level on October 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UNM as a result. In 40 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 47%.
UNM moved below its 50-day moving average on October 23, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UNM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 41%.
The Moving Average Convergence Divergence (MACD) for UNM just turned positive on October 08, 2026. Looking at past instances where UNM's MACD turned positive, the stock continued to rise in 38 of 52 cases over the following month. The odds of a continued upward trend are 73%.
The 10-day moving average for UNM crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +0.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where UNM advanced for three days, in 255 of 360 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
UNM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Profit vs. Risk Rating rating for this company is 2 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 4 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. UNM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 60 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.322) is normal, around the industry mean (1.310). P/E Ratio (20.898) is within average values for comparable stocks, (19.517). Projected Growth (PEG Ratio) (0.040) is also within normal values, averaging (0.463). Dividend Yield (0.022) settles around the average of (0.047) among similar stocks. P/S Ratio (1.187) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
AFL | MET | UNM | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 22 | 42 | 90 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 77 Overvalued | 54 Fair valued | 60 Fair valued | |
PROFIT vs RISK RATING 1..100 | 3 | 23 | 2 | |
SMR RATING 1..100 | 94 | 99 | 95 | |
PRICE GROWTH RATING 1..100 | 47 | 26 | 47 | |
P/E GROWTH RATING 1..100 | 87 | 12 | 4 | |
SEASONALITY SCORE 1..100 | 75 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MET's Valuation (54) in the Life Or Health Insurance industry is in the same range as UNM (60) and is in the same range as AFL (77). This means that MET's stock grew similarly to UNM’s and similarly to AFL’s over the last 12 months.
UNM's Profit vs Risk Rating (2) in the Life Or Health Insurance industry is in the same range as AFL (3) and is in the same range as MET (23). This means that UNM's stock grew similarly to AFL’s and similarly to MET’s over the last 12 months.
AFL's SMR Rating (94) in the Life Or Health Insurance industry is in the same range as UNM (95) and is in the same range as MET (99). This means that AFL's stock grew similarly to UNM’s and similarly to MET’s over the last 12 months.
MET's Price Growth Rating (26) in the Life Or Health Insurance industry is in the same range as AFL (47) and is in the same range as UNM (47). This means that MET's stock grew similarly to AFL’s and similarly to UNM’s over the last 12 months.
UNM's P/E Growth Rating (4) in the Life Or Health Insurance industry is in the same range as MET (12) and is significantly better than the same rating for AFL (87). This means that UNM's stock grew similarly to MET’s and significantly faster than AFL’s over the last 12 months.
| AFL | MET | UNM | |
|---|---|---|---|
| RSI ODDS (%) | 3 days ago 45% | 3 days ago 55% | N/A |
| Stochastic ODDS (%) | 3 days ago 45% | 3 days ago 54% | 3 days ago 50% |
| Momentum ODDS (%) | 3 days ago 60% | 3 days ago 54% | 3 days ago 47% |
| MACD ODDS (%) | 3 days ago 64% | 3 days ago 49% | 3 days ago 73% |
| TrendWeek ODDS (%) | 3 days ago 56% | 3 days ago 55% | 3 days ago 41% |
| TrendMonth ODDS (%) | 3 days ago 54% | 3 days ago 54% | 3 days ago 37% |
| Advances ODDS (%) | 12 days ago 54% | 4 days ago 65% | 4 days ago 71% |
| Declines ODDS (%) | 25 days ago 38% | 26 days ago 52% | 7 days ago 41% |
| BollingerBands ODDS (%) | 3 days ago 43% | 3 days ago 58% | 3 days ago 70% |
| Aroon ODDS (%) | 3 days ago 44% | 3 days ago 48% | 3 days ago 55% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AFL’s FA Score shows that 1 FA rating(s) are green while MET’s FA Score has 3 green FA rating(s), and UNM’s FA Score reflects 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AFL’s TA Score shows that 5 TA indicator(s) are bullish while MET’s TA Score has 5 bullish TA indicator(s), and UNM’s TA Score reflects 4 bullish TA indicator(s).
AFL (@Life/Health Insurance) experienced а +0.45% price change this week, while MET (@Life/Health Insurance) price change was -1.93% , and UNM (@Life/Health Insurance) price fluctuated -2.11% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +0.70%. For the same industry, the average monthly price growth was -3.55%, and the average quarterly price growth was -4.55%.
AFL is expected to report earnings on Nov 04, 2026.
MET is expected to report earnings on Nov 04, 2026.
UNM is expected to report earnings on Nov 03, 2026.
Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
A.I.dvisor indicates that over the last year, AFL has been loosely correlated with CNO. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if AFL jumps, then CNO could also see price increases.
A.I.dvisor indicates that over the last year, UNM has been loosely correlated with CNO. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if UNM jumps, then CNO could also see price increases.